164 related articles for article (PubMed ID: 24568688)
1. High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae.
Sergeev G; Roy S; Jarek M; Zapolskii V; Kaufmann DE; Nandy RK; Tegge W
BMC Microbiol; 2014 Feb; 14():49. PubMed ID: 24568688
[TBL] [Abstract][Full Text] [Related]
2. Selective and Efficient Elimination of
Oh YT; Kim HY; Kim EJ; Go J; Hwang W; Kim HR; Kim DW; Yoon SS
Front Cell Infect Microbiol; 2016; 6():156. PubMed ID: 27900286
[No Abstract] [Full Text] [Related]
3. Identification of Small Molecule Inhibitors of the Pathogen Box against Vibrio cholerae.
Kim H; Burkinshaw BJ; Lam LG; Manera K; Dong TG
Microbiol Spectr; 2021 Dec; 9(3):e0073921. PubMed ID: 34937180
[TBL] [Abstract][Full Text] [Related]
4. Targeting aphA : a new high-throughput screening assay identifies compounds that reduce prime virulence factors of Vibrio cholerae.
Bolger G; Roy S; Zapol'skii VA; Kaufmann DE; Schnürch M; Mihovilovic MD; Nandy RK; Tegge W
J Med Microbiol; 2016 Jul; 65(7):678-687. PubMed ID: 27174292
[TBL] [Abstract][Full Text] [Related]
5. A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae.
Rasmussen L; White EL; Pathak A; Ayala JC; Wang H; Wu JH; Benitez JA; Silva AJ
Antimicrob Agents Chemother; 2011 Sep; 55(9):4134-43. PubMed ID: 21709090
[TBL] [Abstract][Full Text] [Related]
6. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT.
Mondal SI; Khadka B; Akter A; Roy PK; Sultana R
Interdiscip Sci; 2014 Jun; 6(2):108-17. PubMed ID: 25172449
[TBL] [Abstract][Full Text] [Related]
7. AlmG, responsible for polymyxin resistance in pandemic
Henderson JC; Herrera CM; Trent MS
J Biol Chem; 2017 Dec; 292(51):21205-21215. PubMed ID: 29101229
[TBL] [Abstract][Full Text] [Related]
8. Genomic plasticity associated with antimicrobial resistance in
Verma J; Bag S; Saha B; Kumar P; Ghosh TS; Dayal M; Senapati T; Mehra S; Dey P; Desigamani A; Kumar D; Rana P; Kumar B; Maiti TK; Sharma NC; Bhadra RK; Mutreja A; Nair GB; Ramamurthy T; Das B
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6226-6231. PubMed ID: 30867296
[TBL] [Abstract][Full Text] [Related]
9. In vivo fluid accumulation-inhibitory, anticolonization and anti-inflammatory and in vitro biofilm-inhibitory activities of methyl gallate isolated from Terminalia chebula against fluoroquinolones resistant Vibrio cholerae.
Bag PK; Roy N; Acharyya S; Saha DR; Koley H; Sarkar P; Bhowmik P
Microb Pathog; 2019 Mar; 128():41-46. PubMed ID: 30578837
[TBL] [Abstract][Full Text] [Related]
10. Roles of NhaA, NhaB, and NhaD Na+/H+ antiporters in survival of Vibrio cholerae in a saline environment.
Herz K; Vimont S; Padan E; Berche P
J Bacteriol; 2003 Feb; 185(4):1236-44. PubMed ID: 12562793
[TBL] [Abstract][Full Text] [Related]
11. Dietary Isothiocyanates, Sulforaphane and 2-Phenethyl Isothiocyanate, Effectively Impair
Krause K; Pyrczak-Felczykowska A; Karczewska M; Narajczyk M; Herman-Antosiewicz A; Szalewska-Pałasz A; Nowicki D
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638525
[No Abstract] [Full Text] [Related]
12. Comparative genomics of Vibrio cholerae O1 isolated from cholera patients in Bangladesh.
Hossain ZZ; Leekitcharoenphon P; Dalsgaard A; Sultana R; Begum A; Jensen PKM; Hendriksen RS
Lett Appl Microbiol; 2018 Oct; 67(4):329-336. PubMed ID: 29981154
[TBL] [Abstract][Full Text] [Related]
13. Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada.
Mangat CS; Boyd D; Janecko N; Martz SL; Desruisseau A; Carpenter M; Reid-Smith RJ; Mulvey MR
Antimicrob Agents Chemother; 2016 Jan; 60(3):1819-25. PubMed ID: 26824956
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance in Vibrio cholerae El Tor strains isolated during cholera complications in Siberia and the Far East of Russia.
Gladkikh AS; Feranchuk SI; Ponomareva AS; Bochalgin NO; Mironova LV
Infect Genet Evol; 2020 Mar; 78():104096. PubMed ID: 31689544
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB.
Matson JS; Yoo HJ; Hakansson K; Dirita VJ
J Bacteriol; 2010 Apr; 192(8):2044-52. PubMed ID: 20154134
[TBL] [Abstract][Full Text] [Related]
16. Carbapenemase VCC-1-Producing Vibrio cholerae in Coastal Waters of Germany.
Hammerl JA; Jäckel C; Bortolaia V; Schwartz K; Bier N; Hendriksen RS; Guerra B; Strauch E
Emerg Infect Dis; 2017 Oct; 23(10):1735-1737. PubMed ID: 28930017
[TBL] [Abstract][Full Text] [Related]
17. The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides.
Mathur J; Waldor MK
Infect Immun; 2004 Jun; 72(6):3577-83. PubMed ID: 15155667
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in Vibrio cholerae strains isolated from clinical specimens.
Rahmani F; Fooladi AA; Marashi SM; Nourani MR
Acta Microbiol Immunol Hung; 2012 Mar; 59(1):77-84. PubMed ID: 22510289
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Susceptibility Testing (AST) Reports: A Basis for Environmental/Epidemiological Surveillance and Infection Control Amongst Environmental
Igere BE; Okoh AI; Nwodo UU
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32781601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
